A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies.
Alexander G S OldroydAndrew B AllardJeffrey P CallenGabriela Arredondo Hector ChinoyLorinda ChungDavid FiorentinoMichael D GeorgePatrick GordonKate KolstadDrew J B KurtzmanPedro M MachadoNeil J McHughAnna PostolovaAlbert Selva-O'CallaghanJens SchmidtSarah L TansleyRuth Ann VleugelsVictoria P WerthRohit AggarwalPublished in: Rheumatology (Oxford, England) (2021)
Cancer risk factors should be evaluated in patients with IIM for risk stratification. Screening evidence is limited but CT scanning could be useful. Prospective studies and consensus guidelines are needed to establish cancer screening strategies in IIM patients.
Keyphrases
- papillary thyroid
- risk factors
- squamous cell
- end stage renal disease
- clinical practice
- computed tomography
- ejection fraction
- magnetic resonance imaging
- chronic kidney disease
- newly diagnosed
- high resolution
- lymph node metastasis
- oxidative stress
- young adults
- childhood cancer
- peritoneal dialysis
- patient reported outcomes